Annalisa Piersanti

Annalisa Piersanti is currently a Business Insights and Analytics Specialist at Novo Nordisk since June 2023. Prior experience includes serving as an Associate at LSC - LifeSciences Consultants from January 2021 to May 2024, where contributions to global projects and leadership in physician-based market research were significant. Annalisa has a strong background in strategic consulting within the Pharmaceuticals and Biotech sectors as a Business Analyst, focusing on go-to-market strategies, market trends, and primary research across various therapeutic areas, including Central Nervous System disorders, rare diseases, and oncology. Previous roles include consulting for BDM Associati SRL, internships at Frontier Economics and DgComp, and a research assistantship with the Chief Economist Team at the European Commission. Annalisa holds a Master’s degree in Economics and Social Sciences from Università Bocconi and a Bachelor’s degree in Economics and Social Sciences, complemented by an exchange program at Northwestern University.